-
1
-
-
0032572432
-
Radikal prostatektomi for lokaliseret cancer prostatae
-
Brasso K, Iversen P. Radikal prostatektomi for lokaliseret cancer prostatae. Ugeskr Læger 1998; 160: 4505-9.
-
(1998)
Ugeskr Læger
, vol.160
, pp. 4505-4509
-
-
Brasso, K.1
Iversen, P.2
-
2
-
-
0033532405
-
Skal radikal prostatektomi indføres? Med svar af Peter Iversen
-
Gøtzsche PC. Skal radikal prostatektomi indføres? Med svar af Peter Iversen. Ugeskr Læger 1999; 161: 3472-3.
-
(1999)
Ugeskr Læger
, vol.161
, pp. 3472-3473
-
-
Gøtzsche, P.C.1
-
3
-
-
84862718984
-
-
København: Den Almindelige Danske Lægeforening, (Haringsrapport; nr. 4)
-
Iversen P, Rasmussen F, Mogensen P, Lundbeck F, Poulsen J, Roosen JU et al. Prostatacancer. Betænkning fra en arbejdsgruppe under Dansk Uro-Onkologisk Udvalg 1998. København: Den Almindelige Danske Lægeforening, 1999. (Haringsrapport; nr. 4).
-
(1999)
Prostatacancer. Betænkning fra en Arbejdsgruppe under Dansk Uro-Onkologisk Udvalg 1998
-
-
Iversen, P.1
Rasmussen, F.2
Mogensen, P.3
Lundbeck, F.4
Poulsen, J.5
Roosen, J.U.6
-
4
-
-
0026444924
-
The TNM classification of prostate cancer
-
Schröder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. The TNM classification of prostate cancer. Prostate Suppl 1992; 4: 129-38.
-
(1992)
Prostate Suppl
, vol.4
, pp. 129-138
-
-
Schröder, F.H.1
Hermanek, P.2
Denis, L.3
Fair, W.R.4
Gospodarowicz, M.K.5
Pavone-Macaluso, M.6
-
5
-
-
0016608092
-
Grading of prostatic carcinoma
-
Mostofi FK. Grading of prostatic carcinoma. Cancer Chemother Rep 1975; 159: 111-7.
-
(1975)
Cancer Chemother Rep
, vol.159
, pp. 111-117
-
-
Mostofi, F.K.1
-
6
-
-
0013890366
-
Classification of prostatic carcinomas
-
Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep 1966; 50: 125-8.
-
(1966)
Cancer Chemother Rep
, vol.50
, pp. 125-128
-
-
Gleason, D.F.1
-
7
-
-
0025735945
-
Sexual function following radical prostatectomy: Influence of preservation of neurovascular bundles
-
Quinlan DM, Epstein JI, Carter BS, Walsh PC. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol 1991; 145: 998-1002.
-
(1991)
J Urol
, vol.145
, pp. 998-1002
-
-
Quinlan, D.M.1
Epstein, J.I.2
Carter, B.S.3
Walsh, P.C.4
-
9
-
-
85047690589
-
A structured literature review of treatment for localized prostate cancer
-
Wasson JH, Cushman CC, Bruskewitz RC, Littenberg B, Mulley A Jr, Wennberg JE. A structured literature review of treatment for localized prostate cancer. Arch Fam Med 1993; 2: 487-93.
-
(1993)
Arch Fam Med
, vol.2
, pp. 487-493
-
-
Wasson, J.H.1
Cushman, C.C.2
Bruskewitz, R.C.3
Littenberg, B.4
Mulley Jr., A.5
Wennberg, J.E.6
-
10
-
-
0030891731
-
Population-based study of long-term survival in patients with clinically localised prostate cancer
-
Lu-Yao GL, Yao SL. Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet 1997; 349: 906-10.
-
(1997)
Lancet
, vol.349
, pp. 906-910
-
-
Lu-Yao, G.L.1
Yao, S.L.2
-
11
-
-
0032871236
-
Downward trend in prostate cancer mortality in Quebec and Canada
-
Meyer F, Moore L, Bairati I, Fradet Y. Downward trend in prostate cancer mortality in Quebec and Canada. J Urol 1999; 161: 1189-91.
-
(1999)
J Urol
, vol.161
, pp. 1189-1191
-
-
Meyer, F.1
Moore, L.2
Bairati, I.3
Fradet, Y.4
-
12
-
-
0033575051
-
Cancer surveillance series: Interpreting trends in prostae cancer - Part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality and survival rates
-
Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC et al. Cancer surveillance series: interpreting trends in prostae cancer - part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality and survival rates. J Natl Cancer Inst 1999; 91: 1017-24.
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 1017-1024
-
-
Hankey, B.F.1
Feuer, E.J.2
Clegg, L.X.3
Hayes, R.B.4
Legler, J.M.5
Prorok, P.C.6
-
13
-
-
0028948183
-
Management of early prostatic cancer in the Nordic countries: Variations in clinical policies and physicians' attitudes toward radical treatment options
-
Jonsson PM, Danneskiold-Samsøe B, Heggestad T, Iversen P, Leisti S. Management of early prostatic cancer in the Nordic countries: variations in clinical policies and physicians' attitudes toward radical treatment options. Int J Tech Ass 1995; 11: 66-78.
-
(1995)
Int J Tech Ass
, vol.11
, pp. 66-78
-
-
Jonsson, P.M.1
Danneskiold-Samsøe, B.2
Heggestad, T.3
Iversen, P.4
Leisti, S.5
-
14
-
-
0027813110
-
Serum PSA after anatomic radical prostatectomy. The John Hopkins experience after 10 years
-
Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Serum PSA after anatomic radical prostatectomy. The John Hopkins experience after 10 years. Urol Clin N Am 1993; 20: 713-25.
-
(1993)
Urol Clin N Am
, vol.20
, pp. 713-725
-
-
Partin, A.W.1
Pound, C.R.2
Clemens, J.Q.3
Epstein, J.I.4
Walsh, P.C.5
-
15
-
-
0028125318
-
5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer
-
Catalona WJ, Smith DS. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 1994; 152: 1837-42.
-
(1994)
J Urol
, vol.152
, pp. 1837-1842
-
-
Catalona, W.J.1
Smith, D.S.2
-
16
-
-
0033935812
-
Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: Continued risk of biochemical failure after 5 years
-
Amling CL, Blute ML, Bergstralh EJ, Seay TM, Slezak J, Zincke H. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol 2000; 164: 101-5.
-
(2000)
J Urol
, vol.164
, pp. 101-105
-
-
Amling, C.L.1
Blute, M.L.2
Bergstralh, E.J.3
Seay, T.M.4
Slezak, J.5
Zincke, H.6
-
17
-
-
0029059020
-
Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxMo) prostate cancer
-
Soloway MS, Sharrifi R, Wajsman Z, Mcleod D, Wood DP Jr, Pura-Baez A. Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxMo) prostate cancer. J Urol 1995; 154: 424-8.
-
(1995)
J Urol
, vol.154
, pp. 424-428
-
-
Soloway, M.S.1
Sharrifi, R.2
Wajsman, Z.3
Mcleod, D.4
Wood Jr., D.P.5
Pura-Baez, A.6
-
18
-
-
0033526309
-
Natural history of progression after PSA elevation following radical prostatectomy
-
Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 1591-97.
-
(1999)
JAMA
, vol.281
, pp. 1591-1597
-
-
Pound, C.R.1
Partin, A.W.2
Eisenberger, M.A.3
Chan, D.W.4
Pearson, J.D.5
Walsh, P.C.6
-
19
-
-
0027845218
-
Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: The first controlled and randomized trial
-
Labrie F, Dupont A, Cusan L, Gomez J, Diamond P, Koutsilieris M et al. Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trial. Clin Invest Med 1993; 16: 499-509.
-
(1993)
Clin Invest Med
, vol.16
, pp. 499-509
-
-
Labrie, F.1
Dupont, A.2
Cusan, L.3
Gomez, J.4
Diamond, P.5
Koutsilieris, M.6
-
20
-
-
0001757501
-
Patient-reported complications and follow-up treatment after radical prostatectomy
-
Fowler JE Jr, Barry MJ, Lu-Yao GL, Roman A, Wasson J, Wennberg JE. Patient-reported complications and follow-up treatment after radical prostatectomy. Urology 1993; 42: 623-9.
-
(1993)
Urology
, vol.42
, pp. 623-629
-
-
Fowler Jr., J.E.1
Barry, M.J.2
Lu-Yao, G.L.3
Roman, A.4
Wasson, J.5
Wennberg, J.E.6
|